SEC Form 4 · accession 0001624073-17-000010
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alistair Macdonald
Officer — Chief Executive Officer · Director
Period of report
Aug 17, 2017
Accepted (ET)
Aug 21, 2017 · 7:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 17, 2017 | M | 8,828 | $10.57 | A | 110,629 | D | |
| Class A Common StockF2 | Aug 17, 2017 | S | 8,828 | $55.648 | D | 101,801 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $10.57 | Aug 17, 2017 | M | 8,828 | D | — | Aug 17, 2022 | Class A Common Stock | 8,828 | 8,828 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2016.
- F2The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $55.57 to $55.75, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- F3The shares subject to this option vested on August 1, 2017.